C3is Inc. (NASDAQ:CISS – Get Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 1,630,000 shares, an increase of 13.2% from the May 31st total of 1,440,000 shares. Based on an average daily volume of 1,980,000 shares, the days-to-cover ratio is currently 0.8 days. Currently, 36.4% of the company’s shares are sold short.
C3is Stock Down 0.7 %
Shares of C3is stock traded down $0.01 during trading hours on Monday, hitting $1.38. The company’s stock had a trading volume of 171,146 shares, compared to its average volume of 1,117,540. The company has a market capitalization of $510,785.00 and a PE ratio of 0.05. The business has a fifty day moving average of $1.47 and a 200 day moving average of $13.77. C3is has a 1-year low of $1.11 and a 1-year high of $144.00.
C3is (NASDAQ:CISS – Get Free Report) last issued its quarterly earnings data on Tuesday, May 28th. The company reported $1.11 EPS for the quarter. The company had revenue of $12.79 million for the quarter. C3is had a return on equity of 22.99% and a net margin of 32.12%.
C3is Company Profile
C3is Inc offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil.
Recommended Stories
- Five stocks we like better than C3is
- Golden Cross Stocks: Pattern, Examples and Charts
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How Technical Indicators Can Help You Find Oversold Stocks
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for C3is Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3is and related companies with MarketBeat.com's FREE daily email newsletter.